Patents by Inventor Christopher M. H. Newman

Christopher M. H. Newman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods, systems, and kits for intravascular nucleic acid delivery
    Patent number: 6794369
    Abstract: Nucleic acid transfection of vascular smooth muscle cells is enhanced by the application of vibrational energy to the cells. By applying vibrational energy at frequency in the range from 1 kHz to 10 MHz and at an intensity in the range from 0.01 W/cm2 to 100 W/cm2, significant enhancement of the uptake of nucleic acids into vascular smooth muscle cells can be achieved.
    Type: Grant
    Filed: August 9, 2002
    Date of Patent: September 21, 2004
    Assignee: Pharmasonics
    Inventors: Christopher M. H. Newman, Axel F. Brisken
  • Methods, systems, and kits for intravascular nucleic acid delivery
    Publication number: 20030040501
    Abstract: Nucleic acid transfection of vascular smooth muscle cells is enhanced by the application of vibrational energy to the cells. By applying vibrational energy at frequency in the range from 1 kHz to 10 MHz and at an intensity in the range from 0.01 W/cm2 to 100 W/cm2, significant enhancement of the uptake of nucleic acids into vascular smooth muscle cells can be achieved.
    Type: Application
    Filed: August 9, 2002
    Publication date: February 27, 2003
    Applicant: Pharmasonics, Inc.
    Inventors: Christopher M.H. Newman, Axel F. Brisken
  • Methods, systems, and kits for intravascular nucleic acid delivery
    Publication number: 20020082238
    Abstract: Nucleic acid transfection of vascular smooth muscle cells is enhanced by the application of vibrational energy to the cells. By applying vibrational energy at frequency in the range from 1 kHz to 10 MHz and at an intensity in the range from 0.01 W/cm2 to 100 W/cm2, significant enhancement of the uptake of nucleic acids into vascular smooth muscle cells can be achieved.
    Type: Application
    Filed: March 1, 2002
    Publication date: June 27, 2002
    Applicant: PHARMASONICS, INC.
    Inventors: Christopher M.H. Newman, Axel F. Brisken
  • Methods, systems, and kits for intravascular nucleic acid delivery
    Patent number: 6372498
    Abstract: Nucleic acid transfection of vascular smooth muscle cells is enhanced by the application of vibrational energy to the cells. By applying vibrational energy at frequency in the range from 1 kHz to 10 MHz and at an intensity in the range from 0.01 W/cm2 to 100 W/cm2, significant enhancement of the uptake of nucleic acids into vascular smooth muscle cells can be achieved.
    Type: Grant
    Filed: December 30, 1998
    Date of Patent: April 16, 2002
    Assignee: Pharmasonics, Inc.
    Inventors: Christopher M. H. Newman, Axel F. Brisken
  • METHODS, SYSTEMS, AND KITS FOR INTRAVASCULAR NUCLEIC ACID DELIVERY
    Publication number: 20010007861
    Abstract: Nucleic acid transfection of vascular smooth muscle cells is enhanced by the application of vibrational energy to the cells. By applying vibrational energy at frequency in the range from 1 kHz to 10 MHz and at an intensity in the range from 0.01 W/cm2 to 100 W/cm2, significant enhancement of the uptake of nucleic acids into vascular smooth muscle cells can be achieved.
    Type: Application
    Filed: December 30, 1998
    Publication date: July 12, 2001
    Inventors: CHRISTOPHER M.H. NEWMAN, AXEL F. BRISKEN